Our Interview with Ioannis Koutroulis, Associate Dean of MD Admissions & Susan Kulp, Faculty Director of MBA Programs

November 9, 2026

Ioannis Koutroulis is the Associate Dean of MD Admissions, and Susan Kulp is the Faculty Director of MBA Programs.

Can you share the vision behind GWU’s MD/MBA dual-degree program and how it prepares students to combine clinical medicine with business, leadership, and healthcare management?

The vision for GW’s MD/MBA program is grounded in the reality that physicians increasingly practice within complex healthcare systems. Clinical excellence remains fundamental, but many of the decisions that ultimately affect patients, such as organization of care, resource allocation, new technology adoption, and change management, also require an understanding of management, finance, strategy, operations, and leadership.

The MD/MBA program gives students the opportunity to develop and integrate both perspectives. The medical education teaches students to understand patients, disease, evidence, and clinical decision-making, while the MBA helps them understand organizations, markets, teams, innovation, and the economics of healthcare. Our goal is to develop physicians who can move comfortably between the patient’s bedside and the larger systems in which healthcare is delivered and lead meaningful change.

GW is particularly well positioned for this because of its location in Washington, D.C., where medicine intersects every day with public policy, government, entrepreneurship, technology, and the healthcare industry.‍

What skills and perspectives do students gain from pursuing both an MD and an MBA, and how can this combination help address some of the biggest challenges facing today's healthcare system?

One of the greatest benefits of the MD/MBA is that students learn to look at healthcare problems through more than one lens. Medical education teaches you to ask, “What is the best approach for this patient’s health issue?” Business education adds questions such as, “How do we design a system that can reliably deliver that care to thousands of patients? How do we finance it? How do we measure its success? How do we align people to implement change?”

Students develop skills in leadership, accounting, finance, strategy, operations, organizational behavior, entrepreneurship, data-driven decision-making, and innovation. Just as importantly, they begin to understand how incentives, organizational culture, workforce issues, regulation, and resource constraints influence healthcare delivery.

Many of the biggest challenges in healthcare cannot be solved by clinical knowledge alone. We face rising costs, workforce pressures, difficulty accessing care, rapidly evolving technology, and the need to responsibly integrate tools such as artificial intelligence into clinical practice. Physicians who understand both medicine and the organizational and economic forces surrounding it can help translate promising ideas into solutions that improve care. That translation, from innovation to implementation, is where we believe MD/MBA graduates can have tremendous impact.

What types of career opportunities does the MD/MBA program open up for graduates, particularly in areas such as healthcare administration, entrepreneurship, health policy, and medical innovation?

The combination creates considerable flexibility. Many graduates will remain primarily practicing physicians, but the MBA can prepare them to take on increasing leadership responsibilities within hospitals, health systems, academic medical centers, physician organizations, or healthcare companies. Over time, students’ deep knowledge in medicine and business might lead to positions such as medical director, department or service-line leader, chief medical officer, or senior health-system executive.

Others may pursue entrepreneurship, biotechnology, digital health, medical devices, consulting, venture development, or healthcare investing. For students interested in innovation, understanding both the clinical problem and the business model is particularly powerful. A physician may recognize an unmet clinical need, but bringing a solution to patients requires understanding product development, regulation, financing, implementation, and scale.

Opportunities also exist at the intersection of medicine and health policy, particularly here in Washington. As artificial intelligence and other intelligent technologies transform healthcare, we will increasingly need physicians who can evaluate not only whether a technology works, but how to implement, govern, finance, and safely integrate it into clinical workflows.

The dual degree does not require someone to leave clinical medicine. Its greatest value is that it lets physicians expand their impact from caring for individual patients to improving the organizations and systems that care for entire populations.

What advice would you give to prospective medical students interested in healthcare leadership who are considering an MD/MBA, and what qualities or experiences make someone a strong fit for GWU’s dual-degree program?

We encourage students to first think about why they want the MBA. The strongest candidates are curious about how healthcare works beyond individual clinical encounters and want the tools to improve it. They do not need to enter medical school already knowing that they want to become a hospital executive or entrepreneur. In fact, part of the program's value is exposure to possibilities students may not yet have considered. What matters more is intellectual curiosity, initiative, an interest in leadership and systems thinking, and a willingness to work across disciplines. We are looking for students who encounter a problem and instinctively begin thinking about how they might build a better solution.

For someone who wants both the privilege of caring for individual patients and the opportunity to influence healthcare on a broader scale, an MD/MBA is a powerful combination. At GW, that combination is especially compelling because students are learning in an environment that prepares them not only to participate in the future of healthcare, but to help shape it.

Ioannis Koutroulis and Susan Kulp, was interviewed by Arush Chandna, the co-founder of Inspira Advantage, a medical school admissions consulting company.